データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
80879-63-6CCOC(=O)c1ccc(OCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)cc1NWWORXYTJRPSMC-QKPAOTATSA-N80879-63-6DTXSID2048799CHEMBL2106304CHEBI:230574説明Emiglitate (BAY O 1248), another deoxynojirimycin analogue is characterized by at least five-fold higher inhibitory potency than acarbose and additionally shows a long-lasting inhibitory effect. In animal studies emiglitate was still active up to 17 h after a single oral administration due to its pharmacokinetic behavior (formation of an active metabolite). Both miglitol and emiglitate differ in their pharmacokinetic behavior from acarbose, which is poorly absorbed (1 – 2 %). The deoxynojirimycin derivatives are structurally related to monosaccharides and will be absorbed in the jejunum.
現在のフィルター条件では反応記録がありません。
読み込み中…